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Introduction
Cough strength predict extubation outcomes of patients
who have passed a spontaneous breathing trial (SBT) (1,2).
Objectives
To evaluate the impact on extubation outcome of prophy-
lactic noninvasive assistance at extubation of patients with
weak cough, and to identify optimal device for assistance.
Methods
Prospective collected database was conducted from
December 2014 to April 2015. Weak cough was defined
by peak expiratory flow (PEF) < 60 L/min. The PEF was
measured with Cosmed Pony Graphic® spirometer v.4.0
S-CZ before extubation, for the patients mechanically ven-
tilated >24 h, who passed successfully SBT at least of 30
min of pressure support 5-8 cmH2O, CPAP, or T-T. The
patients were then extubated regardless the PEF. The
patients with PEF>60 L/min conventional oxygen therapy
was applied, and groups at risk of extubation failure (PEF<
60 L/min) was applied prophylactic noninvasive ventila-
tion (vni) [BiLEVEL/CPAP mode] vs humidified high-flow
nasal cannula (HFNC) randomly. Extubation failure was
defined as the need of reintubation within 48 h following
extubation. We compared both groups of patients accord-
ing to the PEF, and prophylactic assistance on groups
patients with weak cough, on outcome extubation. Contin-
uous variables were expressed as mean ± SD or median
(IRQ) and categorical variables as absolute value and
percentage. The comparison of continuous variables was
performed by Student t test and Mann-Whitney test and
comparison between categorical variables was performed
by Fisher’s exact test and Chi-square test.
Results
Sixty-six patients were studied, 48 males (72,7%). The
two groups of patients according to the PEF, were simi-
lar regarding age, APACHE II, underlying chronic dis-
ease and duration of mechanical ventilation before
extubation. Prophylatic assistance was effectively applied
to 78,3% of patients identified at risk of extubation fail-
ure. Vni was applied at 43,5% (CPAP 17,4% and BiLevel
26,1%), HFNC 56,5%. No significant differences were
found between the prophylactic devices of assistance at
risk group of extubation failure. In the patients with
PEF>60 L/min, extubation failure rate was 16.3% The
higher proportion of extubation failure were in the neu-
rological patients (21,2%). In this group of patients, the
PEF<60 L/min were 27,8%. There were no differences in
ICU admission days in both groups considering the PEF.
Conclusions
Prophylactic assistance to the patients identified with a
weak cough strength at extubation could reduce the risk
of extubation failure. The application of prophylactic
assistance at extubation, also could be beneficial in some
patients with PEF>60 L/min and to reduce extubation
failure. The prophylactic assistance can be applied to any
device and mode (vni or HFNC)
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